Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Philogen
Biotech
BMS expands radiopharma pipeline
The deal centers around OncoACP3, a small-molecule ligand with high affinity for ACP3, a phosphatase that is expressed in prostate cancer.
James Waldron
Jun 11, 2025 4:31am
New immuno-oncology combo attacks glioblastoma in mice
Oct 7, 2020 2:00pm
EuroBiotech Report—Bayer, Merck, F-star, Philogen and roxa data
May 16, 2019 9:59am
Italian cancer startup Philogen gets off impressive $70M round
May 13, 2019 8:38am
